https://www.selleckchem.com/pr....oducts/bms-986235.ht
hildren. ClinicalTrials.gov NCT03916029 . Registered on 16 April 2019. ClinicalTrials.gov NCT03916029 . Registered on 16 April 2019. Lymphangioleiomyomatosis (LAM) is a rare multisystem disease characterized by cystic lung disease and extrapulmonary manifestations, including lymphatic system disorder. The objective of this study was to investigate the findings of Ga-NOTA-Evans Blue (NE PET/CT in LAM and compare it with that of Tc-ASC lymphoscintigraphy. Ten patients diagnosed with LAM according to the American Thoracic Society/Japa
Like
Comment
Share
